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The management of odontogenic keratocysts (OKC) remains a hotly debated topic in oral and maxillofacial surgery. Despite numerous studies and 
systematic reviews on treatment options, there is a lack of consensus and no accepted protocol on the management of OKC. Hence, the aim of this 
study was to briefly summarize all large systematic reviews in the literature on the management of OKC and formulate an evidence-based management 
protocol. Data from five large systematic reviews were combined to calculate the mean recurrence rate for each technique. Decompression followed by 
enucleation along with adjuvant methods such as application of Carnoy’s solution and peripheral ostectomy can result in very low recurrence and is an 
acceptable first line treatment. The surgical approach should be determined by lesion size, patient age, proximity to vital structures, accessibility, soft 
tissue/cortical perforation, and if the lesion is recurrent.
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Numerous surgical methods have been practiced in the 
management of odontogenic keratocysts (OKC); however, 
much confusion still exists as to which methods provide the 
lowest recurrence rates (RR) without causing significant 
morbidity. These methods are divided into conservative 
and aggressive/radical approaches or a combination of the 
two. Conservative methods include simple enucleation and 
marsupialization/decompression1. Adjuvant methods such 
as peripheral ostectomy, cryotherapy (liquid nitrogen) and 
Carnoy’s solution are considered aggressive forms of treat-
ment which have shown more promising outcomes1. Radical 
methods involve mainly resection which yields the lowest 
RR however causes significant morbidity1. 
It is currently considered that enucleation alone is an inad-
equate form of treatment and needs to be used in combination 
with adjuvant methods to lower RR2,3. Epithelial remnants 
and satellite/daughter cysts can easily be left behind after 
enucleation which leads to high RR (20.8%-26.1%)4. 
Decompression is a modified marsupialization technique 
which causes the cyst to decrease significantly in size and 
the cystic lining becomes thicker resembling oral mucosa 
that allows for easier enucleation2. This method decreases the 
levels of IL-1α which regulates epithelial cell proliferation 
in OKC; hence, there is immune-histochemical evidence that 
decompression is superior to enucleation alone2. de Castro et 
al.4 reported RR of OKC treated by decompression followed 
by enucleation (11.9%) to be significantly lower than enucle-
ation alone (20.8%). 
Peripheral ostectomy is an aggressive form of adjuvant 
therapy where methylene blue is utilized to stain any cystic 
remnants and a rosehead bur is used to remove these2. Cryo-
therapy with liquid nitrogen causes cell necrosis of the cystic 
lining as with chemical curettage with Carnoy’s solution2. 
All these methods reduce RR when compared to enucleation 
or marsupialization/decompression alone; however, these 
methods can cause damage to adjacent structures2. Resection 
provides the least recurrences (RR, 0%-8.4%)5,6.
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Data from five large systematic reviews reporting on RR 
for different treatment modalities were combined (Table 1) 
and these formed the basis for developing a management pro-
tocol for OKCs1,4-7.(Fig. 1) The protocol highlights the role of 
advanced imaging in OKC management. Magnetic resonance 
imaging (MRI) is the only non-invasive modality that charac-
terizes OKC accurately, preoperatively. T2-weighted images 
show hyper-intensity with signal drop out which is highly 
suggestive of OKC (85% sensitivity)8. Computed tomogra-
phy (CT) can detect cortical perforations8.


















Al-Moraissi et al.1 (2017) 23.10 17.40 11.50 14.50 32.30 14.60 8.40
de Castro et al.4 (2018) 20.80 NA NA NA 18.50 11.90 NA
Chrcanovic and Gomez7 
(2017)
22.50 18.60 5.30 20.90 28.70 18.60 2.20
Johnson et al.5 (2013) 25.60 NA 7.90 30.30 NA 15.80 6.30
Kaczmarzyk et al.6 (2012) 26.09 18.18 50 NA 40 NA 0
Total 23.60 18.10 18.70 21.90 29.90 15.20 4.20
(NA: not available)
Values are presented as %.
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Initial exam & Panorex
Preoperative advanced imaging CT
(MRI - gold standard)
MRI: T2-weighted images show hyper-intensity with signal drop out.
Highly suggestive of OKC (85% sensitivity). CT: detect cortex perforations
Size <4 cm; young/
elderly patients; not close to











then enucleation & peripheral
osteotomy (RR:15.2%)
Yearly follow up (Panorex); MRI









Enucleation & 2 adjuvant Rx
-Peri ostectomy (RR: 18.1%)















Incisional biopsy & excise overlying oral mucosa Frozen section
(if available).
Error rate 35%
Fig. 1.  Management protocol for 
odontogenic keratocysts (OKC). (CT: 
computed tomography, MRI: magnetic 
resonance imaging, IAN: inferior alveolar 
nerve, Rx: treatment, RR: recurrence 
rates)
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Other important factors in lowering the RR of OKC in-
clude excision of the overlying oral mucosa, especially at the 
time of biopsy, as studies have shown that approximately all 
recurrent OKCs contain epithelial islands and micro-cysts in 
the mucosa overlying areas of cortical perforation9. 
The surgical approach is determined by size, patient age, 
proximity to vital structures, accessibility, soft tissue/cortical 
perforation, and if the lesion is recurrent. Age is an important 
factor in the recurrence of OKC, with younger patients (espe-
cially those in their second to third decade of life) experienc-
ing higher RR that should be managed more aggressively10. 
Decompression followed by enucleation has been shown to 
reduce RR (15.2%). If this technique is followed by an ad-
juvant method such as application of Carnoy’s solution and 
peripheral ostectomy, it can result in very low recurrence and 
is an acceptable first line of treatment6. If the lesion is acces-
sible and not large in size, then enucleation of the cyst should 
be performed along with 2 adjuvant methods. Resection 
should be reserved for multiple recurrent lesions, multiple 
cortical perforations, and soft tissue extension. 
OKC should be monitored closely with yearly panoramic 
radiographs2. MRI should be performed every 2 years to 
detect early recurrences8. Follow-up should be for at least 
10 years2. Bone grafting and rehabilitation can be performed 
early in cases of resection, a thin mandibular cortex, and large 
lesions that were treated with cryotherapy2. Bone grafting 
should be delayed in recurrent lesions2.
In conclusion, an evidence-based protocol for management 
of OKCs has been proposed. In order to reduce recurrence 
and morbidity, a systematic approach should be implemented 
based on presenting factors and sound evidence-based treat-
ment options. This protocol can also be used as a valuable 
educational tool for patients.
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